denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: Genmab and AbbVie
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Lymphomas, Education, Diseases, Treatment Considerations, Lymphoid Malignancies, Adverse Events
Hematology Disease Topics & Pathways:
Lymphomas, Education, Diseases, Treatment Considerations, Lymphoid Malignancies, Adverse Events
Friday, December 6, 2024: 3:00 PM-6:00 PM
Marriott Grand Ballroom 11-13
(Marriott Marquis San Diego Marina)
Chair:
Joshua Brody, MD, Icahn School of Medicine at Mount Sinai
Disclosures:
No relevant conflicts of interest to declare.
Speakers:
Krish Patel, MD, Director, Lymphoma Research, Sarah Cannon Research Institute
and
Lorna Warwick, Lymphoma Coalition
Disclosures:
Patel: Curis, Inc: Research Funding; Trillium Therapeutics/Pfizer: Consultancy, Research Funding; Fate Therapeutics: Research Funding; Genentech/Roche: Consultancy, Research Funding; Kite: Consultancy, Research Funding, Speakers Bureau; Loxo Oncology: Consultancy, Research Funding; MEI Pharma: Consultancy, Research Funding; Merck: Consultancy, Research Funding; Morphosys: Consultancy; Nurix: Research Funding; Pharmacyclics/Janssen: Consultancy, Research Funding; Sunesis Pharmaceuticals: Consultancy, Research Funding; TG Therapeutics: Consultancy, Speakers Bureau; Epizyme: Consultancy, Research Funding; Caribou Biosciences: Consultancy; CRISPR Therapeutics: Research Funding; Bristol Myers Squibb: Consultancy, Research Funding, Speakers Bureau; BeiGene: Consultancy; AstraZeneca: Consultancy, Research Funding, Speakers Bureau; ADC Therapeutics: Consultancy; Adaptive Biotechnologies: Research Funding; AbbVie: Consultancy; Xencor: Consultancy, Research Funding.
On Demand program will be available here December 21, 2024.
This live panel discussion will focus on the advancing field of bispecific antibodies in third-line relapsed/refractory follicular lymphoma. Experts in the field of follicular lymphoma, with the added perspective of a patient advocate, will review best practices for assessing and applying the latest data on bispecific antibodies, as well as strategies to enhance shared decision-making and patient-centered care.
See more of: Friday Satellite Symposia